In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Clinical Investigation

• Publication date

  1995-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI118156PMID 7657796PMCID PMC185743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development.

  1994cited by this paper
• Transcriptional regulation of T cell receptor genes.

  1993cited by this paper
• Novel and effective gene transfer technique for study of vascular renin angiotensin system.

  1993cited by this paper
• Distinct nuclear proteins competing for an overlapping sequence of cyclic adenosine monophosphate and negative regulatory elements regulate tissue-specific mouse renin gene expression.

  1993cited by this paper
• Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction.

  1993cited by this paper
• Gene injection into canine myocardium as a useful model for studying gene expression in the heart of large mammals.

  1993cited by this paper
• Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.

  1993cited by this paper
• Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney.

  1993cited by this paper
• Behavior of genes directly injected into the rat heart in vivo.

  1992cited by this paper
• Identification of a negative regulatory element involved in tissue-specific expression of mouse renin genes.

  1992cited by this paper
• In vivo function of regulatory DNA sequence elements of a major histocompatibility complex class I gene

  1992cited by this paper
• Identification of a zinc finger protein that inhibits IL-2 gene expression.

  1991cited by this paper
• Prorenin secretion from human placenta perfused in vitro.

  1991cited by this paper
• Hormonal modulation of a gene injected into rat heart in vivo.

  1991cited by this paper
• Structure, Expression, and Regulation of the Murine Renin Genes

  1991cited by this paper
• Negative regulation of the major histocompatibility complex class I promoter in embryonal carcinoma cells.

  1991cited by this paper
• Molecular biology of human renin and its gene.

  1991cited by this paper
• Two silencers regulate the tissue-specific expression of the collagen II gene.

  1990cited by this paper
• The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.

  1990cited by this paper
• Regulation of gene expression with double-stranded phosphorothioate oligonucleotides.

  1990influential reference
• Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication.

  1990cited by this paper
• Increased expression of DNA cointroduced with nuclear protein in adult rat liver.

  1989influential reference
• A FOS protein is present in a complex that binds a negative regulator of MYC.

  1989cited by this paper
• Renin-promoter SV40 large T-antigen transgenes induce tumors irrespective of normal cellular expression of renin genes.

  1989cited by this paper
• The molecular biology of human renin and its gene.

  1989cited by this paper
• Alpha beta lineage-specific expression of the alpha T cell receptor gene by nearby silencers.

  1989cited by this paper
• Recombinant gene expression in vivo within endothelial cells of the arterial wall.

  1989cited by this paper
• Negative control elements and cAMP responsive sequences in the tissue-specific expression of mouse renin genes.

  1989cited by this paper
• Identification of negative and positive regulatory elements in the human renin gene.

  1989cited by this paper
• Extra-renal transcription of the renin genes in multiple tissues of mice and rats.

  1989cited by this paper
• αβ lineage-specific expression of the α T cell receptor gene by nearby silencers

  1989cited by this paper
• Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines.

  1989cited by this paper
• Studies on the regulation of renin genes using transgenic mice.

  1988cited by this paper
• Molecular biology of the renin-angiotensin system.

  1988cited by this paper
• A simple phase-extraction assay for chloramphenicol acyltransferase activity.

  1988cited by this paper
• Activity of two different silencer elements of the chicken lysozyme gene can be compensated by enhancer elements.

  1987cited by this paper
• Regulated expression of the Ren‐2 gene in transgenic mice derived from parental strains carrying only the Ren‐1 gene.

  1987cited by this paper
• CAT vectors for analysis of eukaryotic promoters and enhancers.

  1986cited by this paper
• Ren-1 and Ren-2 loci are expressed in mouse kidney.

  1985cited by this paper
• Molecular cloning of two distinct renin genes from the DBA/2 mouse.

  1982cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Genetic Variations Related to Angiotensin II Production and Risk for Basal Cell Carcinoma

  2024cites this paper
• Kidney-selective gene transfection using anionic bubble lipopolyplexes with renal ultrasound irradiation in mice.

  2014cites this paper
• Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with decreased risk for basal cell carcinoma

  2013cites this paper
• Transfection of NF-kappaB decoy oligodeoxynucleotides into macrophages reduces murine fatal liver failure after excessive hepatectomy.

  2009cites this paper
• A single nucleotide mutation in the mouse renin promoter disrupts blood pressure regulation.

  2008cites this paper
• In Vivo Reduction of the Nuclear Factor-κB Activity Using Synthetic cis-Element Decoy Oligonucleotides Suppresses Intimal Hyperplasia in the Injured Carotid Arteries in Rabbits

  2007cites this paper
• Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer

  2007cites this paper
• Molecular mechanism of juxtaglomerular cell hyperplasia: a unifying hypothesis.

  2007cites this paper
• Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease

  2007cites this paper
• TP10, a delivery vector for decoy oligonucleotides targeting the Myc protein.

  2005cites this paper
• Targeted disruption of transcriptional regulatory function of p53 by a novel efficient method for introducing a decoy oligonucleotide into nuclei

  2005cites this paper
• Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis.

  2004cites this paper
• Site-specific kidney-targeted plasmid DNA transfer using nonviral techniques

  2004cites this paper
• Identification of a novel region in the proximal promoter of the mouse renin gene critical for expression.

  2004cites this paper
• Kidney-targeted naked DNA transfer by retrograde injection into the renal vein in mice.

  2004cites this paper
• Transcription factors as molecular targets: molecular mechanisms of decoy ODN and their design.

  2003cites this paper
• Identification of a Novel Set of Genes Regulated by a Unique Liver X Receptor-α-mediated Transcription Mechanism*

  2003cites this paper
• Renal gene transfer

  2003cites this paper
• Oligonucleotide-based molecular therapy for restenosis after angioplasty.

  2003cites this paper
• Nuclear factor κB decoy oligodeoxynucleotides prevent endotoxin‐induced fatal liver failure in a murine model

  2003cites this paper
• Gene therapy with transcription factor decoy oligonucleotides as a potential treatment for cardiovascular diseases.

  2003cites this paper
• Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model.

  2003cites this paper
• Transcription factor decoy.

  2002cites this paper
• Renal gene therapy.

  2001cites this paper
• Inhibition of TNF-alpha, induced cytokine and adhesion molecule. Expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB.

  2001cites this paper
• Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice

  2001cites this paper
• Inhibition of TNF-α, Induced Cytokine and Adhesion Molecule

  2001cites this paper
• Evaluating a Model of an NRE Mediated Tissue-Specific Expression of Murine Renin Genes

  2001cites this paper
• Increased renin immunostaining in preglomerular arterioles after myocardial infarction in the rat.

  2001cites this paper
• ACE gene polymorphism and diabetic complications: is there a connection?

  2000cites this paper
• ACE Gene Polymorphism and Diabetic Complications

  2000cites this paper
• Therapeutic applications of transcription factor decoy oligonucleotides.

  2000cites this paper
• Cyclic mechanical distension regulates renin gene transcription in As4.1 cells.

  2000cites this paper
• Transcription factor decoy for NFκB inhibits TNF-α-induced cytokine and adhesion molecule expression in vivo

  2000cites this paper
• Regulation of renin: new evidence from cultured cells and genetically modified mice

  2000cites this paper
• Gene therapy as a potential treatment for restenosis and myocardial infarction.

  2000cites this paper
• Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo.

  2000cites this paper
• Endotoxin-induced Renal Inflammatory Response

  2000cites this paper
• Angiotensin‐converting enzyme gene and diabetes mellitus

  1999cites this paper
• Transcription factor decoy to study the molecular mechanism of negative regulation of renin gene expression in the liver in vivo.

  1999cites this paper
• Angiotensinogen gene-activating elements regulate blood pressure in the brain.

  1999cites this paper
• Intratumoral injection of oligonucleotides to the NFκB binding site inhibits cachexia in a mouse tumor model

  1999cites this paper
• Lipoplexes and Tumours. A Review

  1999cites this paper
• , Activating Elements Regulate Blood Pressure in the Brain − Angiotensinogen Gene

  1999cites this paper
• Transcription factor decoy for nuclear factor‐κB inhibits tumor necrosis factor‐α‐induced expression of interleukin‐6 and intracellular adhesion molecule‐1 in endothelial cells

  1998cites this paper
• Characterization of the human type II Na/Pi-cotransporter promoter

  1998cites this paper
• Transcription Factors Sp1 and Sp3 Alter Vascular Endothelial Growth Factor Receptor Expression through a Novel Recognition Sequence*

  1998cites this paper
• Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site.

  1998cites this paper
• Functional Analysis of Tissue Renin-Angiotensin System Using “Gain and Loss of Function” Approaches: In Vivo Test of in Vitro Hypothesis

  1998cites this paper
• An oligonucleotide decoy for transcription factor E 2 F inhibits mesangial cell proliferation in vitro

  1998cites this paper
• Molecular approaches to renal physiology and therapeutics.

  1998cites this paper
• An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro.

  1998cites this paper
• Oligonucleotide-Based Gene Therapy for Cardiovascular Disease

  1998cites this paper
• Gene Therapy for Myocardial Infarction

  1998cites this paper
• Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease.

  1998cites this paper
• In vivo evaluation of in vitro hypothesis using "gain or loss" of function: functional analysis of renin-angiotensin system.

  1998cites this paper
• Genetic manipulation of the kidney

  1997cites this paper
• In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction

  1997cites this paper
• A novel strategy for gene therapy and gene regulation analysis using transcription factor decoy oligonucleotides.

  1997cites this paper
• Expression and localization of human kallistatin in rat submandibular gland after intracapsular gene injection.

  1997cites this paper
• Gene therapy for renal diseases.

  1997cites this paper
• Enhanced Anticancer Therapy Mediated by Specialized Liposomes

  1997cites this paper
• Manipulation of transcription factor activity using fluorescein-tagged dumbbell oligonucleotides.

  1997cites this paper
• Gene transfer into the kidney: promises and limitations.

  1997cites this paper
• Cationic Liposomes and Gene Therapy for Solid Tumors

  1997cites this paper
• Angiotensin-converting enzyme gene polymorphism and cardiovascular endocrine system in coronary angiography patients.

  1997cites this paper
• Polymorphisms of the renin-angiotensin system genes in progressive renal diseases.

  1996cites this paper
• Role of transcriptional cis-elements, angiotensinogen gene-activating elements, of angiotensinogen gene in blood pressure regulation.

  1996cites this paper
• Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.

  1996cites this paper
• Role of Proximal Promoter Elements in Regulation of Renin Gene Transcription*

  1996cites this paper
• In vivo gene transfer and gene modulation in hypertension research.

  1996cites this paper